CompanyGraph
Shanghai Runda Medical Technology Co., Ltd.
603108 · SSE · China
rundamedical.comFinancials as of FY2025
At a glance
- Depends onMidstream position: 6 outgoing, 6 incoming connections
- ScaleRevenue is $1B, above the global median of $548.88M
- PositionDebt-to-equity is 1.38×, higher than 95% of its Diagnostics & Research peers (median 0.15×)
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
5.80BCNY866.10M · vs all stocks (USD)
Revenue (TTM)
6.72BCNY1.00B · vs all stocks (USD)
Profit Margin
-7.67%vs Diagnostics & Research peers
Beta
0.5320xvs all stocks
52-Week Change
-41.00%vs all stocks
Market Capitalization
5.80BCNY866.10M · vs all stocks (USD)
Enterprise Value
12.50BCNY1.87B · vs all stocks (USD)
Forward P/E
13.15xvs Diagnostics & Research peers
Price to Sales (TTM)
0.8635xvs Diagnostics & Research peers
Price to Book (MRQ)
1.50xvs Diagnostics & Research peers
Enterprise to Revenue
1.86xvs Diagnostics & Research peers
Enterprise to EBITDA
34.83xvs Diagnostics & Research peers
Gross Margin
25.61%vs Diagnostics & Research peers
Profit Margin
-7.67%vs Diagnostics & Research peers
Operating Margin
6.02%vs Diagnostics & Research peers
Return on Assets (TTM)
0.38%vs Diagnostics & Research peers
Return on Equity (TTM)
-9.53%vs Diagnostics & Research peers
Revenue (TTM)
6.72BCNY1.00B · vs all stocks (USD)
Revenue per Share (TTM)
11.12CNYUpdated Sep 20, 2026Quarterly Revenue Growth
-6.90%vs Diagnostics & Research peers
Gross Profit (TTM)
1.55BCNY231.55M · vs all stocks (USD)
EBITDA (TTM)
581.92MCNY86.83M · vs all stocks (USD)
Net Income (TTM)
-515.61MCNY-76.94M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
1.29%vs Diagnostics & Research peers
Operating Cash Flow (TTM)
756.71MCNY112.92M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
621.25MCNY92.70M · vs all stocks (USD)
Payout Ratio
166.67%vs Diagnostics & Research peers
Minority Interest (Equity)
1.10BCNYFY2025 · Dec 31, 2025Revenue
7.00BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
5.50BCNYFY2025 · Dec 31, 2025Gross Profit
1.50BCNYFY2025 · Dec 31, 2025Operating Income
204.62MCNY30.53M · vs all stocks (USD)
Pre-tax Income
-460.64MCNYFY2025 · Dec 31, 2025Income Tax Expense
57.51MCNYFY2025 · Dec 31, 2025Net Income
-518.15MCNYFY2025 · Dec 31, 2025EBIT
-181.71MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
581.92MCNYFY2025 · Dec 31, 2025Research & Development
108.01MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
438.77MCNYFY2025 · Dec 31, 2025Other Operating Expenses
112.91MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
10.98MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
278.93MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.9100CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.9100CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
602.63MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
602.63MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-518.15MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-30.24MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-858.12MCNYFY2025 · Dec 31, 2025Free Cash Flow
-1.09BCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
667.05MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-518.15MCNYFY2025 · Dec 31, 2025Other Non-cash Items
307.94MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-70.25MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-577.67MCNYFY2025 · Dec 31, 2025Capital Expenditures
-232.67MCNYFY2025 · Dec 31, 2025Purchase of Investments
-559.78MCNYFY2025 · Dec 31, 2025Sale of Investments
552.12MCNYFY2025 · Dec 31, 2025Other Investing Activity
856.96KCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-239.46MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
7.58BCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-7.69BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-281.35MCNYFY2025 · Dec 31, 2025Other Financing Charges
-92.19MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-479.76MCNYFY2025 · Dec 31, 2025Shares Outstanding
604.60MSharesUpdated Sep 20, 2026Float Shares
420.43MSharesUpdated Sep 20, 2026% Held by Insiders
31.76%vs all stocks
% Held by Institutions
2.72%vs all stocks
Total Cash (MRQ)
781.89MCNY116.67M · vs all stocks (USD)
Total Cash per Share (MRQ)
1.29CNYUpdated Sep 20, 2026Total Debt (MRQ)
6.48BCNY967.21M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.38xvs Diagnostics & Research peers
Current Ratio (MRQ)
1.06xvs Diagnostics & Research peers
Book Value per Share (MRQ)
6.40CNYUpdated Sep 20, 2026Total Assets
13.42BCNY2.00B · vs all stocks (USD)
Total Current Assets
8.52BCNYFY2025 · Dec 31, 2025Total Liabilities
8.54BCNYFY2025 · Dec 31, 2025Total Non-current Assets
4.90BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
857.58MCNYFY2025 · Dec 31, 2025Total Current Liabilities
7.68BCNYFY2025 · Dec 31, 2025Cash
667.05MCNYFY2025 · Dec 31, 2025Cash Equivalents
348.80MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
1.02BCNYFY2025 · Dec 31, 2025Other Short-term Investments
129.80MCNYFY2025 · Dec 31, 2025Accounts Receivable
4.46BCNYFY2025 · Dec 31, 2025Inventory
1.73BCNYFY2025 · Dec 31, 2025Accounts Payable
1.22BCNYFY2025 · Dec 31, 2025Short-term Debt
6.06BCNYFY2025 · Dec 31, 2025Other Current Liabilities
21.46MCNYFY2025 · Dec 31, 2025Long-term Debt
708.16MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
5.69MCNYFY2025 · Dec 31, 2025Common Stock (Book)
603.68MCNYFY2025 · Dec 31, 2025Retained Earnings
1.77BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
4.88BCNY728.41M · vs all stocks (USD)
52-Week Low
8.70CNYUpdated Sep 20, 202652-Week High
20.77CNYUpdated Sep 20, 202652-Week Change
-41.00%vs all stocks
Beta
0.5320xvs all stocks
50-Day MA
9.82CNYUpdated Sep 20, 2026200-Day MA
12.92CNYUpdated Sep 20, 2026Avg 10-Day Volume
11.09MSharesUpdated Sep 20, 2026Avg 30-Day Volume
16.67MSharesUpdated Sep 20, 2026Diluted EPS (TTM)
-0.8600CNYUpdated Sep 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsWhere is this company structurally exposed?
Down-Close Share With Multi-Year Earnings Decrease
Most weeks closed down this year, and earnings and gross profit fell over four.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Debt-to-equity is 1.38×, higher than 95% of its Diagnostics & Research peers (median 0.15×)Significant
Debt-to-equity: 1.38Industry median: 0.15Industry P95: 1.36Peers compared: 30.00
Financial Health
Altman Z-Score 1.14: grey zoneSignificant
Altman Z-Score: 1.14
Supply Chain
Midstream position: 6 outgoing, 6 incoming connectionsNotable
Outgoing: 6.00Incoming: 6.00
High connectivity hub: 12 industry connectionsNotable
Total Connections: 12.00
Scale
Revenue is $1B, above the global median of $548.88MNotable
Revenue (USD): 1,003,019,842.99Global Median: 548,883,780.48
Levered free cash flow is $92.7M, above the global median of $18.73MNotable
Levered free cash flow (USD): 92,702,922.612Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Wetown Electric Group Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Kunshan Topa Intelligent Equipment Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Hit Welding Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Wellhope Foods Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Xingye Leather Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Jiangsu Changbao Steeltube Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
Aces Electronic Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Sinoseal Holding Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRisk
GVS S.p.A.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Aksa Akrilik Kimya Sanayii A.Ş.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Suzhou Jinfu Technology Co., Ltd.
1 interpretationDown-Close Share With Multi-Year Earnings Decrease
Trs Information Technology Co.
1 interpretationDown-Close Share With Multi-Year Earnings Decrease
Sdic Intelligence Co., Ltd.
1 interpretationDown-Close Share With Multi-Year Earnings Decrease